Zobrazeno 1 - 10
of 18
pro vyhledávání: '"James Polega"'
Publikováno v:
Vaccines, Vol 11, Iss 3, p 688 (2023)
Strategies to combat COVID-19 include vaccines and Monoclonal Antibody Therapy. While vaccines aim to prevent development of symptoms, Monoclonal Antibody Therapy aims to prevent the progression of mild to severe disease. An increasing number of COVI
Externí odkaz:
https://doaj.org/article/8ad81ee3df65451983c9e245b04db557
Autor:
Mudita Bhugra, Aaron Chang, James Polega, Jorgelina De Sanctis, Derek Vanderhorst, Habiba Hassouna
Publikováno v:
Open Forum Infectious Diseases. 9
Background Dalbavancin is a lipoglycopeptide with prolonged half-life currently approved for treatment of bacterial skin and soft tissue infections. Off-label uses of dalbavancin include multiple Gram-positive infections requiring long-term antibioti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23e144ac7cbf964a2f1a51a46fd1c912
https://doi.org/10.1093/ofid/ofac492.1360
https://doi.org/10.1093/ofid/ofac492.1360
Autor:
Joshua D Donkin, Rebecca P Emery, James Polega, Curtis J Behenna, Adam J Caulfield, Gordana Simeunovic
Publikováno v:
Open Forum Infectious Diseases. 9
Background Despite advances in microbiologic techniques, for patients with complex infections it often remains a challenge to identify the causative infectious pathogen. Traditional cultures (Cx) may fail to grow microorganisms due to inadequate samp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::253ad68e074070ab491a1003b8fb21c6
https://doi.org/10.1093/ofid/ofac492.589
https://doi.org/10.1093/ofid/ofac492.589
Publikováno v:
Open Forum Infectious Diseases. 9
Background Clinical trials of monoclonal antibodies therapy (MAB) for COVID-19 demonstrated the risk reduction of COVID related hospitalization and death of any cause if administered within the first 7 days from the symptom onset. The Food and Drug A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b61cba0939acd4f0a84cb612685789b9
https://doi.org/10.1093/ofid/ofac492.986
https://doi.org/10.1093/ofid/ofac492.986
Publikováno v:
Open Forum Infectious Diseases. 9
Background Strategies to combat COVID include vaccines and Monoclonal Antibody Therapy (MAB). While vaccines aim to prevent symptom development, MAB aims to prevent progression of mild symptoms to severe. Increasing numbers of COVID infections in vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07b55733312d195150da6f33ca38a3f2
https://doi.org/10.1093/ofid/ofac492.989
https://doi.org/10.1093/ofid/ofac492.989
Publikováno v:
American journal of infection control.
The COVID-19 pandemic presented unique and unprecedented challenges due to limited knowledge regarding the virus's transmissibility. With guidance from the Center for Disease Control (CDC), healthcare systems instituted widespread visitor restriction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::642d2c512f6ed79fa40c20b2006ed9cd
https://pubmed.ncbi.nlm.nih.gov/36470450
https://pubmed.ncbi.nlm.nih.gov/36470450
Publikováno v:
Open Forum Infectious Diseases. 8:S438-S438
Background Respiratory infections are a common cause of hospital admissions resulting in significant morbidity and mortality. Isolating specific pathogens from the respiratory tract is a diagnostic challenge. Traditional testing modalities are prone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e72e681d511a4913fab4f2d5dd7399de
https://doi.org/10.1093/ofid/ofab466.868
https://doi.org/10.1093/ofid/ofab466.868
Publikováno v:
Journal of Pediatrics & Neonatal Care. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb0eb0334a376ac32e6d56f95e59d2b1
https://doi.org/10.15406/jpnc.2018.08.00351
https://doi.org/10.15406/jpnc.2018.08.00351
Publikováno v:
Surgery for Obesity and Related Diseases. 11:S132-S133
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c7f8060181a421f1d3460e72ed04dff
https://doi.org/10.1016/j.soard.2015.08.200
https://doi.org/10.1016/j.soard.2015.08.200
Publikováno v:
Open Forum Infectious Diseases. 2023 Supplement, Vol. 10, pS1-S1274. 3913p.